“Embedded in Lupin is a formula for growth which fuels creativity, performance and innovation”
It was Dr. Desh Bandhu Gupta’s vision and passion which helped him grow a small dream into a large company with a global footprint.
The most advanced pharmaceutical product development
Developing new chemical entities for focused therapy areas
Producing quality medicines in areas of unmet needs
Producing high quality affordable and accessible biologics
Financial Result
Share Capital
Press Releases
Press Kit
BSE -
NSE -
As at March 31, 2020
See accompanying notes forming part of the financial statements
For the year ended March 31, 2020
(3,859.2)
(8,113 1)
Notes :
Cash comprises cash on hand and current accounts with banks. Cash equivalents are short-term balances (with an original maturity of three months or less from the date of acquisition), current investments that are convertible into known amounts of cash and which are subject to insignificant risk of changes in value.
TEN YEARS FINANCIAL SUMMARY
CONSOLIDATED BALANCE SHEET (₹ in million)
CONSOLIDATED STATEMENT OF PROFIT AND LOSS (₹ in million)
Standalone
DOWNLOAD NOW
File size : 318 KB
File size : 279 KB
File size : 284 KB
File size : 252 KB
File size : 230 KB
File size : 256 KB
File size : 203 KB
File size : 236 KB
File size : 275 KB
File size : 330 KB
File size : 338 KB
File size : 354 KB
2017 | 2018 | 2019 | 2020
2017 | 2018 | 2019
2017 | 2018
2018 | 2019 | 2020
2018 | 2019
CLICK HERE
Consolidated Related Party Transactions for half year ended September 30, 2020
Consolidated Related Party Transactions for half year ended March 31, 2020
Consolidated Related Party Transactions For half year ended September 30, 2019
Consolidated Related Party Transactions For half year ended March 31, 2019
ANNUAL GENERAL MEETING